IVF Study Shows One Embryo is Best
By Rebecca Brice,
ABC News
| 07. 05. 2012
Australian researchers have discovered that the rate of perinatal deaths in IVF (in vitro fertilisation) can be considerably reduced when only one embryo is used in the fertility treatment.
Researchers at the University of NSW say Australia is leading the world in single embryo IVF transfers and they are using a conference in Istanbul to get the message out to the rest of the world.
They studied the records of more than 50,000 women from Australia and New Zealand between 2004 and 2008 and found the risk of an IVF baby being stillborn or dying within the first month of life was 53 per cent higher when two embryos were implanted instead of one.
Dr Michael Chapman from the NSW University School of Women's and Children's Health says Australia established the ideal of single embryo transfer in its code of practice seven years ago.
"Because we have a database which includes all cycles ever done in Australia, we can look back and see those outcomes and that's the decision around the table of all the IVF directors," he said.
Dr...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...